One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Trump, Health, Science, and the Next 4 Years
doi : 10.1016/S0140-6736(24)02518-2
Volume 404, Issue 10466, 16–22 November 2024, Page 1897
Opening the Door to Widespread iPSC-Derived Regenerative Therapy for Corneal Epithelial Opacity
Glofit-GemOx: A New Treatment Paradigm in Relapsed or Refractory Diffuse Large B-Cell Lymphoma?
Health Taxes: Missed Opportunities for Health and Health-Care Financing
Non-Communicable Diseases: Can Implementation Research Change the Game for Policy and Practice?
Pernkopf Was Not Alone: The Nazi Origins of the Spalteholz–Spanner Atlas
Misinformation Targeting Replicon Vaccine Recipients: An Urgent Public Health Ethical Issue
Refugees and Asylees With Disabilities: A Call for Economic Integration
Induced Pluripotent Stem-Cell-Derived Corneal Epithelium for Transplant Surgery: A Single-Arm, Open-Label, First-in-Human Interventional Study in Japan
Glofitamab Plus Gemcitabine and Oxaliplatin (GemOx) Versus Rituximab-GemOx for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (STARGLO): A Global Phase 3, Randomised, Open-Label Trial
Global, Regional, and National Stillbirths at 20 Weeks' Gestation or Longer in 204 Countries and Territories, 1990–2021: Findings From the Global Burden of Disease Study 2021
Central Conducting Lymphatic Anomaly With Pulmonary Lymphatic Dysplasia Causes Restrictive Lung Disease and Chronic Pleural Effusion
